Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply
Lancet Infect Dis
.
2021 Jun;21(6):e146.
doi: 10.1016/S1473-3099(20)30681-2.
Epub 2020 Dec 7.
Authors
John C Marshall
1
,
Srinivas Murthy
2
,
Janet Diaz
3
;
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection
Affiliations
1
St Michael's Hospital, Toronto, ON M5B 1W8, Canada. Electronic address: john.marshall@unityhealth.to.
2
The University of British Columbia, Vancouver, BC, Canada.
3
World Health Organization, Geneva, Switzerland.
PMID:
33301729
PMCID:
PMC7831982
DOI:
10.1016/S1473-3099(20)30681-2
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19*
Data Collection
Humans
Mycoses*
Outcome Assessment, Health Care
SARS-CoV-2
Grants and funding
001/WHO_/World Health Organization/International